Democratizing Dermatology with AI
Our brands
Our mission
We are creating Dermatology 2.0
Our mission is to disrupt the old physician-centric medical system and put the patient in the center.
There are currently 3 billion people in the world that suffer from skin problems.
90% of them will never see a dermatologist due to expensive treatment costs and lack of access to a decent healthcare system.
Our goal is to provide the best-in-class dermatology treatment to every person with a skin problem.
We use computer vision and AI to provide real-time skin/hair analysis via our mobile applications and then deliver personalized treatment directly to our customers' doorstep.
During the treatment, we provide unlimited one-on-one chat support with our medical support team and continuously fine-tune the product formulations as the skin/hair changes and improves.
Our solutions are the most convenient, effective, and affordable dermatology solutions ever created. And this is just the beginning.
A few numbers
+3M
Customer images analyzed via our skin analysis AI
+400K
Treatments shipped to our customers
2 min
Average time to get the skin assessment results via our app
Our founders
Dr. Yoram Harth
Chief Medical Officer
Board-Certified Dermatologist
Dr. Yoram Harth is a world-renowned Dermatologist, a former research fellow at the Department of Dermatology Columbia Presbyterian in New York, and author of dozens of scientific publications. Dr. Harth is the winner of the Wall Street Journal-Europe and the Edison award for his innovations in the treatment of Dermatology and aesthetic medicine.
Oded Harth
CEO
Forbes '30 Under 30'
Tech wizard and entrepreneur. Trained in AI and machine learning at Stanford and backed by top Silicon Valley venture capital firms, Oded has founded MDalgorithms (our parent company) with a mission to allow everyone, everywhere, effective, easy, and affordable skin and hair treatment. Builder of MDacne, the world-leading customized skin treatment application, and MDhair, the first medical-grade customized hair regrowth treatment.
Backed by
